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Arginine methylation is a novel post-translational modification within the voltage-gated ion 
channel superfamily, including the cardiac sodium channel, NaV1.5. We show that NaV1.5 R513 
methylation decreases S516 phosphorylation rate by 4 orders of magnitude, the first evidence of 
PKA inhibition by arginine methylation. Reciprocally, S516 phosphorylation blocks R513 
methylation. NaV1.5 p.G514C, associated to cardiac conduction disease, abrogates R513 
methylation, while leaving S516 phosphorylation rate unchanged. This is the first report of 
methylation - phosphorylation cross-talk of a cardiac ion channel. 
 








Arginine methylation is emerging as a common post-translational modification of voltage-gated 
ion channels (Beltran-Alvarez et al. 2014, Guo et al. 2014). Arginine methylation is catalyzed 
by protein arginine methyltransferases (PRMT)§, which transfer methyl groups from S-
adenosyl- L-methionine (SAM) to produce mono- or dimethylated arginines (Pang et al. 2010). 
We have recently described that the α subunit of the cardiac voltage-gated sodium channel, 
NaV1.5, is methylated by PRMT3 (Beltran-Alvarez et al. 2013).  
NaV1.5 is responsible for the fast sodium current that initiates cardiomyocyte action 
potentials. It is a large protein (ca. 2,000 residues) containing 24 transmembrane segments 
allocated in four homologous domains, DI to DIV, which are joined by cytosolic, interdomain 
linkers. The linker between domains DI and DII has been identified as a hot-spot of post-
translational modifications that modulate NaV1.5 function, including arginine methylation, and 
phosphorylation. NaV1.5 residues R513 and R526 are mono- or dimethylated (Beltran-Alvarez 
et al. 2011). Additionally, there are 11 phosphorylated serines, including S516, S524 and S525, 
which are targets for kinases such as cAMP-dependent protein kinase (PKA), (Marionneau et al. 
2012, Herren et al. 2013). The fine-tuned regulation of NaV1.5 current is vital for proper cardiac 
function, which is exemplified by the fact that single mutations in NaV1.5 can lead to serious 
cardiac disorders, including cardiac conduction disease (Tan et al. 2001). 
In our original report of NaV1.5 methylation, we had speculated that arginine 
methylation could regulate phosphorylation of adjacent phosphosites (Beltran-Alvarez et al. 
2011). Here, we describe the interplay between NaV1.5 R513 methylation and S516 
phosphorylation. 
 
Materials and Methods 
 
The manuscript does not contain clinical studies or patient data. 
 
In vitro methylation and phosphorylation assays 
 
Peptides were synthesized by the Laboratory of Proteomics and Protein Chemistry, University 
Pompeu Fabra, and isolated to 98 % purity. We used 15,000 recombinant murine PKA α 
isoform (EC 2.7.11.11) units, and 500 µM ATP (both from New England Biolabs, Ipswich, 
MA, product numbers P6000L and P0756L) in 20 µL phosphorylation reactions. PKA reaction 
buffer (pH 7.5) was provided by the manufacturer. Human PRMT3 (EC 2.1.1.125) was 
expressed in E. coli as GST fusion and purified following published protocols (Zurita-Lopez et 
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al. 2012). PRMT3 preparations contained (mM): 50 Tris, 150 NaCl, 10 reduced glutathione, pH 
= 7.4. SAM (Sigma) concentration was 200 µM.  
All phosphorylation and methylation reactions were started by addition of the peptide, 
and then incubated at 30 ºC with shaking (400 rpm). At desired time points, aliquots were taken 
and reactions stopped by addition of 1 % formic acid. Samples were kept at -20 ᵒC until 
analysis. All reactions were done in triplicate. 
To identify methylation sites, RS_long methylated by PRMT3 as above was incubated 
with trypsin (Promega) for 2 hours at 37 ᵒC, and we analyzed the resulting peptide fragments by 
matrix-assisted laser desorption ionization - time of flight (MALDI-TOF) as described below. 
 
MALDI-TOF analysis of methylation and phosphorylation 
 
Peptides were directly spotted onto a Bruker Anchor Chip 384-spot MALDI target plate (Bruker 
Daltonics) using α-cyano-4-hydroxy-cinnamic acid as matrix. Mass spectra (m/z 900 - 4000) 
were acquired using an Ultraflex MALDI-TOF mass spectrometer (Bruker Daltonics) in the 
positive ion mode. Between 500 and 1,000 shots / sample were performed. Spectra were 
analyzed using FlexAnalysis v.2.0. The extent of reaction was calculated as the ratio (area 
phosphorylated peptide) / (area unmodified peptide), and it was less than 15 % in all cases. For 
every substrate concentration, 5 - 7 time points were used to calculate initial rates. We used the 
Michaelis-Menten formalism to fit reaction rate data (shown as mean ± SD).  
 
LC-MS/MS analysis of methylation and phosphorylation 
 
Tandem mass spectrometry was done in the Proteomics Platform, University of Barcelona. 
RS_short phosphorylated by PKA (see above) was analyzed in a nanoAcquity liquid 
chromatographer (Waters) – LTQ Orbitrap Velos Pro (Thermo) mass spectrometer. Peptides 
(m/z 350-1700) were analyzed in data dependent mode in the Orbitrap with a resolution of 
60,000 FWHM at 400 m/z. The 10 most abundant peptides were fragmented using collision 
induced dissociation (CID) in a linear ion trap. Data were collected with Thermo Xcalibur 
(v.2.1.0.1140). Searches were performed using the Sequest search engine (Proteome Discoverer 
v.1.3.0.339) against a database containing common laboratory contaminants and the sequence of 
RS_short. The PhosphoRS node was used to provide a confidence measurement of the 
phosphorylation site. 
 To search for mutual exclusivity of NaV1.5 arginine methylation and phosphorylation in 
a cellular model, we used our previously obtained LC-MS/MS characterization of NaV1.5 
overexpressed in HEK293 cells (Beltran-Alvarez et al. 2011). Searches were done using 
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Sequest, as before, against a database containing common laboratory contaminants and NaV1.5 
sequence. 
 
Molecular dynamics  
 
Molecular dynamics simulations of RS_short and RmeS_short assessed the different 
conformational states explored by peptides in solution. See Supplemental Methods for details. 
 
Results and Discussion 
 
First, we used the synthetic peptide RS_short (Table 1) as a substrate for PKA in vitro. PKA 
readily monophosphorylated RS_short (Figure 1, Panel a, and Online Resources S1 and S2). 
The main phosphorylation site was S516 (pRS node site probability: 99.7 %, Online Resource 
S3) although, due to the resolution of our mass spectrometric analyses, we cannot rule out the 
possibility of a very small population of RS_short having an unexpected modification site. 
Introduction of a methyl group at position R513 decreased RmeS_short phosphorylation rate 
(Figure 1, Panel a, and Online Resource S2), and the specificity constant (Vmax / KM) was 
reduced by ca. 26-fold (Figure 1, Panel b). We propose that this effect was due to arginine 
methylation within the PKA consensus motif (RRxS/T), which may impose additional 
hydrophobic / steric constraints and jeopardize PKA binding. An alternative would be that 
arginine methylation alters peptide folding, but molecular dynamics simulations of RS_short 
and RmeS_short predicted superimposable secondary structures (Online Resource S4).  
PRMT3 asymmetrically dimethylates its substrates (Tang et al. 1998). R513 asymmetric 
dimethylation in the peptide Rme2S_short reduced Vmax / KM by ca. 10,000-fold compared to 
RS_short (Figure 1, Panels a, and b). Given our evidence, it appears that S516 phosphorylation 
rate may be determined by R513 methylation state, although there could be other mechanisms 
occurring in vivo that cannot be explored with our current approach.  
Our mass spectrometric analyses assumed that MALDI-TOF performance of RS_short, 
RmeS_short, and Rme2S_short was similar. This was supported by the observation that 
MALDI-TOF analysis of a mixture containing 0.1 µg / µL each peptide rendered peaks of 
comparable intensities (Online Resource S5). Although RS_short, RmeS_short, and 
Rme2S_short phosphorylation was not expected to affect mass spectrometric properties (Steen 
et al. 2006), kinetic parameters in this work should be regarded as apparent constants. In any 
event, our approach was suitable for comparing different substrates (Pahlich et al. 2005, Kang et 
al. 2008, Köbel et al. 2009). 
Having described how R513 methylation defines S516 phosphorylation rate, we asked 
whether S516 phosphorylation could, in turn, modulate R513 methylation. We initially 
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performed methylation experiments using RS_long, which included 12 residues at the C 
terminus of RS_short, and which was a better substrate for PRMT3 (Online Resource S6). 
Methylation assays using RS_long indicated that R513 was the preferential methylation site 
(Online Resource S7). To eliminate any residual activity of PRMT3 towards non-R513 arginine 
residues, we synthesized the peptide RS_long_K, where R517, R523 and R526 were substituted 
for lysines. RS_long_K was efficiently mono- and dimethylated by PRMT3 (Figure 1, Panel c).  
To test the effect of S516 phosphorylation on R513 methylation, we performed 
experiments using the peptide RpS_long_K. We could not detect methylation of RpS_long_K (1 
µg / µL) after 8 h reactions (Figure 1, Panel d). This indicated that S516 phosphorylation 
abrogated R513 methylation.  
To validate our results in a cellular system, and to assess whether the antagonistic 
relation of arginine methylation and phosphorylation could be generalized to other NaV1.5 Arg-
Ser pairs, we re-analyzed our original mass spectrometry data of NaV1.5 overexpressed in 
HEK293 cells (Beltran-Alvarez et al. 2011). We set both arginine methylation, and serine 
phosphorylation, as dynamic post-translational modifications. We found methylated R526 only 
in peptides where S524 and S525 were not phosphorylated, and S524 and S525 phosphorylation 
only in peptides where R526 was not modified (Online Resource S8). These observations 
suggest that S524 / S525 phosphorylation, and R526 methylation, are mutually exclusive (Baek 
et al. 2014). Overall, our results suggest a model where arginine methylation may regulate 
NaV1.5 phosphorylation, and viceversa. 
Cross-talk between arginine methylation and phosphorylation has previously been 
described. For instance, methylation of arginines within the Akt kinase consensus motif 
(RxRxxS/T) blocks phosphorylation of BAD proteins (Sakamaki et al. 2011). Conversely, 
phosphorylation of RNA polymerase II inhibits arginine methylation in vitro (Sims et al. 2011). 
In one of the few examples of arginine methylation – phosphorylation interplay in membrane 
proteins, methylation of R1175 of the epidermal growth factor receptor enhanced auto-
phosphorylation of Y1173 (Hsu et al. 2011).  
Our results raise the possibility that pathogenic NaV1.5 mutations alter NaV1.5 
methylation-phosphorylation equilibria. To test for this hypothesis, we evaluated the effect of 
NaV1.5 p.G514C, associated to cardiac conduction disease (Tan et al. 2001), on R513 
methylation and S516 phosphorylation rates. We could not observe methylation of 
RS_long_K_G514C (1 µg / µL) after 8 h reactions (Figure 1, Panel e). This was not entirely 
unexpected, because G514C disrupts the RG consensus methylation motif, thereby introducing 
a non-favored Cys at the +1 position (Guo et al. 2014). In contrast, PKA phosphorylated 
RS_short_G514C with the same efficiency as RS_short (Online Resources S2 and S9). We 
speculate that one of the mechanisms by which NaV1.5 p.G514C leads to cardiac conduction 
disease could be S516 hyperphosphorylation due to R513 methylation blockade. Nevertheless, 
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the translation of our current results to an in vivo context must be done with care. Future studies, 
including mutagenesis of R513 and S516 in the full-length protein, should shed light on how 
post-translational modification of these residues affect e.g. the structure and protein-protein 
interactions of this NaV1.5 region.  
As this manuscript was in preparation, proteomic studies by the group of Trimmer 
identified reciprocal changes in phosphorylation and arginine methylation of the rat brain 
sodium channel (NaV1.2) after seizure (Baek et al. 2014). One of the three methylated arginines 
identified in NaV1.2 was R563, equivalent to R513 in NaV1.5 (Online Resource S10). The 
authors speculate that NaV1.2 R563 methylation regulates phosphorylation of NaV1.2 S568, 
equivalent to S516 or S519 in NaV1.5. Using a completely different approach, we have herein 
characterized the interplay R513 methylation – S516 phosphorylation in NaV1.5 as a model to 
understand how arginine methylation may regulate phosphorylation of voltage-gated sodium 
channels, and viceversa. At a broader level, our results open the door to pharmaceutical 
intervention to balance NaV1.5 methylation - phosphorylation equilibria in cardiopathological 
states, and provide the first evidence that arginine methylation inhibits PKA-catalyzed 
phosphorylation reactions. In this sense, we are currently assessing the hypothesis that arginine 
methylation imposes steric constraints on peptide : PKA catalytic complexes, and our results 
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Table 1 Synthetic peptides used in this work. The RS_short peptide series was used in PKA 
reactions, but could not be used in methylation assays due to lack of activity of PRMT3 towards 
RS_short. The RS_long peptide series was used in PRMT3 reactions, but could not be used in 
phosphorylation assays because the introduction of four extra Ser residues in RS_long led to a 
complex mixture of di-, tri- and quatri-phosphorylated peptides upon incubation with PKA. 
R513 and S516 are bold throughout. Rme: methylated arginine. Rme2: asymmetrically 
dimethylated arginine. pS: phosphorylated serine 
 
Fig. 1 a. Michaelis-Menten plots of RS_short (squares), RmeS_short (circles), and Rme2_short 
(inset, diamonds) phosphorylation by PKA. Note the scale change in the inset. b. Apparent 
kinetic parameters of RS_short, RmeS_short, and Rme2_short phosphorylation by PKA. c. 
Methylation of RS_long_K by PRMT3. Incubation of RS_long_K (expected mass: 2603.420 Da) 
with PRMT3 led to mono- and dimethylated  RS_long_K (expected masses: 2617.447 Da and 
2631.474 Da, respectively). The species at 2625 Da is most likely sodium adduct to RS_long_K. 
d. S516 phosphorylation blocks R513 methylation. MALDI-TOF spectrum of RpS_long_K 
(expected mass: 2683.750 Da) incubated with PRMT3. Methylated species were expected, but 
not observed, at 2697.8 Da (mono-) and 2711.8 Da (dimethylation). The species at 2705.924 
and 2727.930 Da are most likely mono- and disodium adducts to RpS_long_K. e. G514C blocks 
R513 methylation. MALDI-TOF spectrum of RS_long_K_G514C (expected mass: 2649.410 
Da) incubated with PRMT3. Methylated species were expected, but not observed, at 2663.4 Da 
(mono-) and 2677.4 Da (dimethylation). The species at 2671.930 Da is most likely sodium 
adduct to RS_long_K_G514C  
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